ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ABEO Abeona Therapeutics Inc

4.07
0.16 (4.09%)
Última actualización: 10:57:15
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Abeona Therapeutics Inc ABEO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.16 4.09% 4.07 10:57:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.00 3.84 4.16 3.91
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202415:05GLOBEAbeona Therapeutics Provides Regulatory Update on Pz-cel
01/4/202407:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/3/202406:30GLOBEAbeona Therapeutics Reports Full Year 2023 Financial Results..
05/3/202406:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
14/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:05GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
01/2/202406:30GLOBEAbeona Therapeutics Announces Progress Update on Pz-cel..
22/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202406:35EDGAR2Form 8-K - Current report
08/1/202406:30GLOBEAbeona Therapeutics Announces $50 Million Credit Facility
15/12/202306:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
04/12/202315:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202306:30EDGAR2Form 8-K - Current report
27/11/202306:30GLOBEAbeona Therapeutics Announces FDA Accepts and Grants..
13/11/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:35EDGAR2Form 8-K - Current report
13/11/202306:30GLOBEAbeona Therapeutics Reports Third Quarter 2023 Financial..
01/11/202306:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/10/202306:30EDGAR2Form 8-K - Current report
17/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202306:30GLOBEAbeona Therapeutics Submits Biologics License Application to..
22/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202306:30GLOBEAbeona Therapeutics Appoints Madhav Vasanthavada, Ph.D.,..
07/9/202306:30GLOBEAbeona Therapeutics Announces Participation in Upcoming..
30/8/202306:30GLOBEAbeona Therapeutics Announces Positive Pre-BLA Meeting with..
08/8/202307:30EDGAR2Form 8-K - Current report
08/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:30GLOBEAbeona Therapeutics Reports Second Quarter 2023 Financial..
28/7/202306:30GLOBEAbeona Therapeutics Announces Submission of Briefing Package..
25/7/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202307:30GLOBEAbeona Therapeutics Joins Rare Disease Company Coalition
10/7/202309:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/7/202307:41EDGAR2Form 8-K - Current report
07/7/202307:30GLOBEAbeona Therapeutics Announces Closing of $25 Million..

Su Consulta Reciente

Delayed Upgrade Clock